Prophylaxis of cervical cancer
- Authors: Prilepskaya VN1, Bebneva TN1, Prilepskaya V1, Bebneva T1
-
Affiliations:
- Issue: No 1 (2010)
- Pages: 27-31
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278189
- ID: 278189
Cite item
Full Text
Abstract
We discuss the problem of prevention of cervical cancer (CC), in the genesis of which the role of human papillomavirus (HPV) is proved. Integrated approach to prevention and control of cervical cancer includes the various types of action from primary prevention, providing implementation of educational programs to reduce risk factors for cervical cancer and vaccination, to early detection, treatment and palliative care. Prophylactic HPV vaccines are the method of primary prevention of cervical cancer and used to create a persistent and prolonged immune response to the infection. We consider the properties and efficacy of prophylactic HPV vaccines Gardasil and Cervarix.
References
- Башмакова М.А., Савичева А.М. Вирусы папилломы человека и их роль. М.: Медкнига; Н. Новгород: НГМА, 1999. 13 с.
- Башмакова М.А., Савичева А.М. Лабораторная диагностика генитальных инфекций // Проблемы репродукции. 2000. № 1. С.20-24.
- Бернард К, Муги К, Лаб М. Новые подходы к пониманию патогенеза инфекции, вызванной вирусом папилломы человека, с поражением аногенитальной области. Роль кофакторов и сопутствующей инфекции // ЗППП. 1995. № 1. С. 3-12.
- Манухин И.Б., Минкина Г.Н., Геворкян М.А. Генитальная папилломавирусная инфекция. Методические рекомендации. М. 1997.
- Минкина Г.Н., Студеная Л.Б., Левченко Р.Г. Кольпоскопическая диагностика папилломавирусной инфекции шейки матки // Журнал акушерства и женских болезней. Спец. выпуск. 1998. 54 с.
- Прилепская В.Н. Профилактика рака шейки матки // Гинекология. 2007. № 1. С.12-18.
- Роговская С.И., Бебнева Т.Н. Папилломавирусная инфекция гениталий. Клиника и лечение. Заболевания шейки матки. М. 1999.
- Gibbs NF. Anogenital papillomavirus infections in children. Curr Opin Pediatr 1998;10(4):393-97.
- Guimaraes EM, Brasileiro Filho G, Pena SD. Human papillomavirus detection in cervical dysplasias or neoplasias and in condilomata acuminata by in situ hybridization with biotinylated DNA probes. Rev Inst Med Trop San Paulo 1992;34(4):309-14.
- Handley JM, Maw RD, et al. Anogenital warts in children. Clin Exp Dermatol 1993;18(3):241-47.
- Harmsel B, Smedts F, et al. Relationship between human papillomavirus type 16 in the cervix and intraepithelial neoplasia. Obstet Gynecol 1999;93(1):46-50.
- Hatch K. Colposcopy of vaginal and vulvar human papillomavirus and adjacent sites. Obstet Gynecol Clin North Am 1993;20(1):203-15.
- Londesborough P. et al. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 1996;69(5):364-68.
- Longuet M, Beaudenon S, Orth G. Two novel genital human papillomavirus (HPV) types, HPV68, HPV70, related to the potentially oncogenic HPV39. J Clin Microbiol 1996;34(3):738-44.
- Lorincz A, Davies PO. The Hybrid Capture II Assay for the detection of human papillomavirus. Genital Infections & Neoplasia Update 1998;1:18-19.
- Lowhagen GB, Von Krogh G, et al. Genital papillomvirusinfektion. Ett diagnostiki och terapeutiski dilemma. Lakartidningen 1993;46:4109-12.
- Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
- Herrero R, Castellsagué X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003;95:1772-83.
- Münger K, Baldwin A, Edwards KM, et al. Mechanisms of human papillomavirus-induced oncogenesis. J Virol 2004;78:11451-460.
- Schijns V. Immunological concepts of vaccine adjuvant activity. Curr Opin Immunol 2000;12:456-63.
- Schwarz TF. Human papillomavirus-16/18 candidate vaccine adjuvanted with AS04 and its impact on the incidence of cervical cancer. Exp Rev Obstet Gynec 2007;2:293-303.
Supplementary files
